Status:
COMPLETED
Assessment of Quality of Global and Sexual Life and Impact of Surgical and Non Surgical Vaginal Aplasia in Patients With a Rokitansky Syndrome
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Rokitansky Syndrome
Surgical or Vaginal Dilatation of Vaginal Aplasia
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The principal objective is to assess the general health status and the sexual health status of women with Rokitansky syndrome having received a surgical or non surgical treatment. The secondary purpo...
Detailed Description
The MRKH syndrome is a congenital disorder characterized by absence of uterus and at least the two thirds of the vagina, a female phenotype and a normal karyotype XX. These patients have normal ovari...
Eligibility Criteria
Inclusion
- Patient affected with Rokitansky syndrome
- Patient over 18 years old
- Patient care with dilatations or by surgery since 1995
- Patient having started dilatations or having had surgery since at least one year
- Patient who signed the consent
- French patient
- Women with social welfare
Exclusion
- Patient with a serious chronic disease interfering with analysis to be performed in this project.
- Patient can't reading or writing
- Patient with legal protection
Key Trial Info
Start Date :
October 11 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2015
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT01911884
Start Date
October 11 2012
End Date
April 10 2015
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'Endocrinologie et Gynécologie Pédiatriques Hôpital Necker Enfants Malades
Paris, France, 75015